{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "6d2ce2cf-e139-4045-b6b3-802ddfd248c6",
   "metadata": {},
   "source": [
    "# Predicting Clinical Trial Terminations\n",
    "### Notebook 2: Preprocessing & EDA\n",
    "\n",
    "**Author: Clement Chan**\n",
    "\n",
    "---\n",
    "Notes on the notebook:\n",
    "- The previous notebook consists of the raw dataset and the steps involved in cleaning. We also performed preliminary EDA and highlighted the distribution of important columns and analyzed what potential features we should include in the model.\n",
    "- In this notebook, we will complete a second round of more in-depth cleaning and exploratory data analysis. Our goal is to create a baseline model for statistical analysis, prepare for feature engineering and modelling."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f6e280c4-69fe-400d-a5e1-4eb7f0a45cf1",
   "metadata": {},
   "source": [
    "### Data Dictionary for this notebook that is based on clinicaltrials.gov:\n",
    "\n",
    "---\n",
    "\n",
    "| Column | Description                                  |Data Type|\n",
    "|-------|--------------------------------------------|-------|\n",
    "| Study Title | Title of the Clinical Trial           | object |\n",
    "| Study Status | Categorical column displaying the current position of the study | object (could classify into dummies) |\n",
    "| Brief Summary | Short description of the clinical study (Includes study hypothesis) | object |\n",
    "| Study Results | Whether the results are posted (yes or no) | object (turn to binary?)|\n",
    "| Conditions | Primary Disease or Condition being studied     | object |\n",
    "| Interventions | The methods used in the trial to reach the outcome                 | object |\n",
    "| Primary Outcome Measures | Description of specific primary outcome | object |\n",
    "| Secondary Outcome Measures | Description of specific secondary outcome | object |\n",
    "| Sponsor | The corporation or agency that initiates the study | object |\n",
    "| Collaborators | Other organizations that provide support | object |\n",
    "| Sex | All: No limit on eligibility based on sex, Male: Only male participants, Female: Only female participants | object (Could change into binary or dummies) |\n",
    "| Age | Relative age of the participants? Probably need to clarify/change up the name of the values | object (could classify this into dummies)|\n",
    "| Phases | Clinical trial phase of the study (drug)... need to classify this futher. | object (dummies?)|\n",
    "| Enrollment | Total estimated number of participants in a study or total actual enrollment? | float -> int |\n",
    "| Funder Type | Funding type in category? | object (could classify into dummies) |\n",
    "| Study Type | Interventional, Observational, or Expanded Access | object (definitely dummies) |\n",
    "| Study Design | Study design based on study type | object |\n",
    "| Start Date | Estimated/Actual date the first participant was enrolled | object -> date |\n",
    "| Primary Completion Date | Date the final participant was examined for the first outcome | object -> date |\n",
    "| Completion Date | Date the final participant was examined | object -> date |\n",
    "| First Posted | Date the clinical trial was first posted to the public      | object -> date  |\n",
    "| Last Update Posted | Date the clinical trial was last posted to the public   | object -> date |\n",
    "| Locations | Where the clinical study will be held | object |\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b0a868a4-251d-4f72-9d69-c3361ca34940",
   "metadata": {},
   "source": [
    "**Importing Libraries**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "1e667164-1ed8-4b86-ba4c-d6c789bb66dc",
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "import pandas as pd\n",
    "\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7f2c52a1-790f-4f49-a1ff-c7690b39f400",
   "metadata": {},
   "source": [
    "<a id = 'toc'><a/>\n",
    "## Table of Contents\n",
    "\n",
    "---\n",
    "1. [Data Preprocessing](#prep)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ddd3bf0e-f487-4b29-a055-651ead069a58",
   "metadata": {},
   "source": [
    "**Load the dataset**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "0b9df7e6-a323-49c7-a0d4-413cb951e791",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>...</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Effectiveness of a Problem-solving Interventio...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>We will conduct a two-arm individually randomi...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Mental Health Issue (E.G., Depression, Psychos...</td>\n",
       "      <td>behavioral: pride 'step 1' problem-solving int...</td>\n",
       "      <td>Mental health symptoms, The Strengths and Diff...</td>\n",
       "      <td>Mental health symptoms, The adolescent-reporte...</td>\n",
       "      <td>Sangath</td>\n",
       "      <td>Harvard Medical School (HMS and HSDM)|London S...</td>\n",
       "      <td>...</td>\n",
       "      <td>250</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2018-08-20</td>\n",
       "      <td>2019-01-20</td>\n",
       "      <td>2019-02-28</td>\n",
       "      <td>2018-08-14</td>\n",
       "      <td>2019-05-21</td>\n",
       "      <td>Sangath, New Delhi, Delhi, 110016, India</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Oral Ketone Monoester Supplementation and Rest...</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>People who report subjective memory complaints...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cerebrovascular Function|Cognition</td>\n",
       "      <td>other: placebo|dietary_supplement: Î²-ohb</td>\n",
       "      <td>Brain network connectivity, Functional connect...</td>\n",
       "      <td>Working memory, Computer battery to assess wor...</td>\n",
       "      <td>McMaster University</td>\n",
       "      <td>Alzheimer's Society of Brant, Haldimand Norfol...</td>\n",
       "      <td>...</td>\n",
       "      <td>30</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>2023-10-25</td>\n",
       "      <td>2024-08</td>\n",
       "      <td>2024-08</td>\n",
       "      <td>2023-08-15</td>\n",
       "      <td>2023-12-01</td>\n",
       "      <td>McMaster University, Hamilton, Ontario, L8S 4K...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Investigating the Effect of a Prenatal Family ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this study is to measure the di...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Focus: Contraceptive Counseling|Focus: Postpar...</td>\n",
       "      <td>other: family planning counseling let by commu...</td>\n",
       "      <td>Self-reported contraceptive use, 6 months post...</td>\n",
       "      <td>Intent to use contraception in the future, 6 m...</td>\n",
       "      <td>Planned Parenthood League of Massachusetts</td>\n",
       "      <td>Society for Family Planning Research Fund</td>\n",
       "      <td>...</td>\n",
       "      <td>176</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>2013-08</td>\n",
       "      <td>2014-12</td>\n",
       "      <td>2014-12</td>\n",
       "      <td>2013-05-15</td>\n",
       "      <td>2015-08-17</td>\n",
       "      <td>Palestinian Ministry of Health Maternal Child ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Pre-exposure Prophylaxis (PrEP) for People Who...</td>\n",
       "      <td>WITHDRAWN</td>\n",
       "      <td>People who inject drugs (PWID) experience high...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Intravenous Drug Abuse</td>\n",
       "      <td>behavioral: prep uptake/adherence intervention...</td>\n",
       "      <td>PrEP uptake by self-report, measured using 1 i...</td>\n",
       "      <td>Participant satisfaction with intervention con...</td>\n",
       "      <td>Boston University</td>\n",
       "      <td>National Institute on Drug Abuse (NIDA)</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2021-03</td>\n",
       "      <td>2022-03</td>\n",
       "      <td>2022-03</td>\n",
       "      <td>2019-03-11</td>\n",
       "      <td>2021-03-10</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Tailored Inhibitory Control Training to Revers...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Insufficient inhibitory control is one pathway...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Smoking|Alcohol Drinking|Prescription Drug Abu...</td>\n",
       "      <td>behavioral: person-centered inhibitory control...</td>\n",
       "      <td>Inhibitory control performance, Task 1, Perfor...</td>\n",
       "      <td>Far transfer to a task related to inhibitory c...</td>\n",
       "      <td>University of Oregon</td>\n",
       "      <td>none</td>\n",
       "      <td>...</td>\n",
       "      <td>103</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2014-09</td>\n",
       "      <td>2016-04</td>\n",
       "      <td>2016-05</td>\n",
       "      <td>2016-10-26</td>\n",
       "      <td>2016-10-26</td>\n",
       "      <td>University of Oregon, Social and Affective Neu...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows Ã 23 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                         Study Title Study Status  \\\n",
       "0  Effectiveness of a Problem-solving Interventio...    COMPLETED   \n",
       "1  Oral Ketone Monoester Supplementation and Rest...   RECRUITING   \n",
       "2  Investigating the Effect of a Prenatal Family ...    COMPLETED   \n",
       "3  Pre-exposure Prophylaxis (PrEP) for People Who...    WITHDRAWN   \n",
       "4  Tailored Inhibitory Control Training to Revers...    COMPLETED   \n",
       "\n",
       "                                       Brief Summary Study Results  \\\n",
       "0  We will conduct a two-arm individually randomi...            NO   \n",
       "1  People who report subjective memory complaints...            NO   \n",
       "2  The purpose of this study is to measure the di...            NO   \n",
       "3  People who inject drugs (PWID) experience high...            NO   \n",
       "4  Insufficient inhibitory control is one pathway...            NO   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0  Mental Health Issue (E.G., Depression, Psychos...   \n",
       "1                 Cerebrovascular Function|Cognition   \n",
       "2  Focus: Contraceptive Counseling|Focus: Postpar...   \n",
       "3                             Intravenous Drug Abuse   \n",
       "4  Smoking|Alcohol Drinking|Prescription Drug Abu...   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  behavioral: pride 'step 1' problem-solving int...   \n",
       "1           other: placebo|dietary_supplement: Î²-ohb   \n",
       "2  other: family planning counseling let by commu...   \n",
       "3  behavioral: prep uptake/adherence intervention...   \n",
       "4  behavioral: person-centered inhibitory control...   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Mental health symptoms, The Strengths and Diff...   \n",
       "1  Brain network connectivity, Functional connect...   \n",
       "2  Self-reported contraceptive use, 6 months post...   \n",
       "3  PrEP uptake by self-report, measured using 1 i...   \n",
       "4  Inhibitory control performance, Task 1, Perfor...   \n",
       "\n",
       "                          Secondary Outcome Measures  \\\n",
       "0  Mental health symptoms, The adolescent-reporte...   \n",
       "1  Working memory, Computer battery to assess wor...   \n",
       "2  Intent to use contraception in the future, 6 m...   \n",
       "3  Participant satisfaction with intervention con...   \n",
       "4  Far transfer to a task related to inhibitory c...   \n",
       "\n",
       "                                      Sponsor  \\\n",
       "0                                     Sangath   \n",
       "1                         McMaster University   \n",
       "2  Planned Parenthood League of Massachusetts   \n",
       "3                           Boston University   \n",
       "4                        University of Oregon   \n",
       "\n",
       "                                       Collaborators  ... Enrollment  \\\n",
       "0  Harvard Medical School (HMS and HSDM)|London S...  ...        250   \n",
       "1  Alzheimer's Society of Brant, Haldimand Norfol...  ...         30   \n",
       "2          Society for Family Planning Research Fund  ...        176   \n",
       "3            National Institute on Drug Abuse (NIDA)  ...          0   \n",
       "4                                               none  ...        103   \n",
       "\n",
       "  Funder Type      Study Type  \\\n",
       "0       OTHER  INTERVENTIONAL   \n",
       "1       OTHER  INTERVENTIONAL   \n",
       "2       OTHER  INTERVENTIONAL   \n",
       "3       OTHER  INTERVENTIONAL   \n",
       "4       OTHER  INTERVENTIONAL   \n",
       "\n",
       "                                        Study Design  Start Date  \\\n",
       "0  Allocation: RANDOMIZED|Intervention Model: PAR...  2018-08-20   \n",
       "1  Allocation: RANDOMIZED|Intervention Model: CRO...  2023-10-25   \n",
       "2  Allocation: NON_RANDOMIZED|Intervention Model:...     2013-08   \n",
       "3  Allocation: RANDOMIZED|Intervention Model: PAR...     2021-03   \n",
       "4  Allocation: RANDOMIZED|Intervention Model: PAR...     2014-09   \n",
       "\n",
       "  Primary Completion Date Completion Date First Posted Last Update Posted  \\\n",
       "0              2019-01-20      2019-02-28   2018-08-14         2019-05-21   \n",
       "1                 2024-08         2024-08   2023-08-15         2023-12-01   \n",
       "2                 2014-12         2014-12   2013-05-15         2015-08-17   \n",
       "3                 2022-03         2022-03   2019-03-11         2021-03-10   \n",
       "4                 2016-04         2016-05   2016-10-26         2016-10-26   \n",
       "\n",
       "                                           Locations  \n",
       "0           Sangath, New Delhi, Delhi, 110016, India  \n",
       "1  McMaster University, Hamilton, Ontario, L8S 4K...  \n",
       "2  Palestinian Ministry of Health Maternal Child ...  \n",
       "3                                            unknown  \n",
       "4  University of Oregon, Social and Affective Neu...  \n",
       "\n",
       "[5 rows x 23 columns]"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# make sure to not include the index_col\n",
    "df = pd.read_csv('updated_ctg.csv', index_col = 0)\n",
    "\n",
    "# First 5 rows of dataset\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9b896ad3-9252-4ec5-a8bc-602db9eb6c0b",
   "metadata": {},
   "source": [
    "Let's find the total number of rows and columns in the data."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "0fd25472-a13e-4665-a7f2-5405e9b02169",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The dataset has 482350 rows and 23 columns.\n"
     ]
    }
   ],
   "source": [
    "print(f'The dataset has {df.shape[0]} rows and {df.shape[1]} columns.')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d508b7ad-f18f-4d52-b2fc-8355cd647024",
   "metadata": {},
   "source": [
    "Check the information of the dataset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "8da5d301-ffba-4b80-9189-f8b51a938d21",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "Index: 482350 entries, 0 to 482349\n",
      "Data columns (total 23 columns):\n",
      " #   Column                      Non-Null Count   Dtype \n",
      "---  ------                      --------------   ----- \n",
      " 0   Study Title                 482350 non-null  object\n",
      " 1   Study Status                482350 non-null  object\n",
      " 2   Brief Summary               482350 non-null  object\n",
      " 3   Study Results               482350 non-null  object\n",
      " 4   Conditions                  482350 non-null  object\n",
      " 5   Interventions               482350 non-null  object\n",
      " 6   Primary Outcome Measures    482350 non-null  object\n",
      " 7   Secondary Outcome Measures  482350 non-null  object\n",
      " 8   Sponsor                     482350 non-null  object\n",
      " 9   Collaborators               482350 non-null  object\n",
      " 10  Sex                         482350 non-null  object\n",
      " 11  Age                         482350 non-null  object\n",
      " 12  Phases                      482350 non-null  object\n",
      " 13  Enrollment                  482350 non-null  int64 \n",
      " 14  Funder Type                 482350 non-null  object\n",
      " 15  Study Type                  482350 non-null  object\n",
      " 16  Study Design                482350 non-null  object\n",
      " 17  Start Date                  482350 non-null  object\n",
      " 18  Primary Completion Date     482350 non-null  object\n",
      " 19  Completion Date             482350 non-null  object\n",
      " 20  First Posted                482350 non-null  object\n",
      " 21  Last Update Posted          482350 non-null  object\n",
      " 22  Locations                   482350 non-null  object\n",
      "dtypes: int64(1), object(22)\n",
      "memory usage: 88.3+ MB\n"
     ]
    }
   ],
   "source": [
    "df.info()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "bba39713-6f74-4778-8ceb-c53f3a70662e",
   "metadata": {},
   "source": [
    "In the previous notebook, our approach was to drop columns that contain a large amount of missing values, and impute them with the string 'unknown', 'missing', and 'none'. Now, we will target specific columns that seem to have a big impact or significance in determining the `Study Status` variable.\n",
    "\n",
    "Since the `Study Status` column is our main dependent variable that we are predicting. Let's explore the distribution again, and see if we can minimize the amount of unique values or categories.\n",
    "- Start by looking at the value counts\n",
    "- Visualize the distribution of the categories\n",
    "- Group common categories or remove categories that are insignificant to the model."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "8cf48322-3535-43ef-a1ee-515f6151404a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "COMPLETED                    263380\n",
       "RECRUITING                    66150\n",
       "UNKNOWN                       64828\n",
       "TERMINATED                    28014\n",
       "NOT_YET_RECRUITING            20055\n",
       "ACTIVE_NOT_RECRUITING         19702\n",
       "WITHDRAWN                     13716\n",
       "ENROLLING_BY_INVITATION        3931\n",
       "SUSPENDED                      1646\n",
       "NO_LONGER_AVAILABLE             446\n",
       "AVAILABLE                       259\n",
       "APPROVED_FOR_MARKETING          197\n",
       "TEMPORARILY_NOT_AVAILABLE        26\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['Study Status'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "c089256a-7934-4a9a-ae1a-b8c4a15befc9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Visualize counts with a graph\n",
    "plt.figure()\n",
    "\n",
    "df['Study Status'].value_counts().plot(kind='barh')\n",
    "\n",
    "plt.title('Number of Studies in Each study status'.title())\n",
    "plt.ylabel('Study Status')\n",
    "plt.xlabel('Number of Studies')\n",
    "\n",
    "sns.despine()\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ff44ac73-1c66-4f59-971a-b4a13e79e00f",
   "metadata": {},
   "source": [
    "Most of the studies have been completed, which can cause some data imbalance in other classes such as our targeted 'Terminated' category. Let's continue with the cleaning, and see where we can group common categories together starting with the lowest counts `TEMPORARILY_NOT_AVAILABLE`."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "0295de14-bbe5-4e21-9e6d-dc5ffc3a42e1",
   "metadata": {},
   "outputs": [],
   "source": [
    "# this option displays all columns in the dataframe\n",
    "pd.options.display.max_columns = None"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "id": "9e637507-a8c0-4d31-a590-8a173f240565",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>11239</th>\n",
       "      <td>Thrombosomes for Expanded Access Use</td>\n",
       "      <td>TEMPORARILY_NOT_AVAILABLE</td>\n",
       "      <td>Expanded use of Thrombosomes where a clinical ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Bleeding</td>\n",
       "      <td>biological: thrombosomesÂ®</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Cellphire Therapeutics, Inc.</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2020-11-06</td>\n",
       "      <td>2022-01-28</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47190</th>\n",
       "      <td>A Phase I Clinical Study of the Safety, Tolera...</td>\n",
       "      <td>TEMPORARILY_NOT_AVAILABLE</td>\n",
       "      <td>This study is designed to multiple dose and do...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Healthy</td>\n",
       "      <td>drug: hx-1171</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Biotoxtech Co., Ltd</td>\n",
       "      <td>none</td>\n",
       "      <td>MALE</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2013-06-28</td>\n",
       "      <td>2013-06-28</td>\n",
       "      <td>Asan Medical Center, Special City of Seoul, Ko...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53091</th>\n",
       "      <td>Treating Amyotrophic Lateral Sclerosis (ALS) W...</td>\n",
       "      <td>TEMPORARILY_NOT_AVAILABLE</td>\n",
       "      <td>R(+) pramipexole dihydrochloride monohydrate \\...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Amyotrophic Lateral Sclerosis</td>\n",
       "      <td>drug: r(+) pramipexole dihydrochloride monohyd...</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Bennett, James P., Jr., M.D., Ph.D.</td>\n",
       "      <td>University of Pittsburgh|University of Nebraska</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDIV</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2008-01-16</td>\n",
       "      <td>2012-07-25</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53366</th>\n",
       "      <td>Development of a Fall Prevention and Fall Dete...</td>\n",
       "      <td>TEMPORARILY_NOT_AVAILABLE</td>\n",
       "      <td>The investigators plan to conduct a first-stag...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Parkinson's Disease</td>\n",
       "      <td>other: portable motion detector</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Far Eastern Memorial Hospital</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2010-12-20</td>\n",
       "      <td>2010-12-20</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>104237</th>\n",
       "      <td>Post-trial Access for Nipocalimab in Participa...</td>\n",
       "      <td>TEMPORARILY_NOT_AVAILABLE</td>\n",
       "      <td>The purpose of this post-trial access (PTA) pr...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Warm Autoimmune Hemolytic Anemia</td>\n",
       "      <td>drug: nipocalimab</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Janssen Research &amp; Development, LLC</td>\n",
       "      <td>none</td>\n",
       "      <td>unknown</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2022-02-03</td>\n",
       "      <td>2024-01-23</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              Study Title  \\\n",
       "11239                Thrombosomes for Expanded Access Use   \n",
       "47190   A Phase I Clinical Study of the Safety, Tolera...   \n",
       "53091   Treating Amyotrophic Lateral Sclerosis (ALS) W...   \n",
       "53366   Development of a Fall Prevention and Fall Dete...   \n",
       "104237  Post-trial Access for Nipocalimab in Participa...   \n",
       "\n",
       "                     Study Status  \\\n",
       "11239   TEMPORARILY_NOT_AVAILABLE   \n",
       "47190   TEMPORARILY_NOT_AVAILABLE   \n",
       "53091   TEMPORARILY_NOT_AVAILABLE   \n",
       "53366   TEMPORARILY_NOT_AVAILABLE   \n",
       "104237  TEMPORARILY_NOT_AVAILABLE   \n",
       "\n",
       "                                            Brief Summary Study Results  \\\n",
       "11239   Expanded use of Thrombosomes where a clinical ...            NO   \n",
       "47190   This study is designed to multiple dose and do...            NO   \n",
       "53091   R(+) pramipexole dihydrochloride monohydrate \\...            NO   \n",
       "53366   The investigators plan to conduct a first-stag...            NO   \n",
       "104237  The purpose of this post-trial access (PTA) pr...            NO   \n",
       "\n",
       "                              Conditions  \\\n",
       "11239                           Bleeding   \n",
       "47190                            Healthy   \n",
       "53091      Amyotrophic Lateral Sclerosis   \n",
       "53366                Parkinson's Disease   \n",
       "104237  Warm Autoimmune Hemolytic Anemia   \n",
       "\n",
       "                                            Interventions  \\\n",
       "11239                           biological: thrombosomesÂ®   \n",
       "47190                                       drug: hx-1171   \n",
       "53091   drug: r(+) pramipexole dihydrochloride monohyd...   \n",
       "53366                     other: portable motion detector   \n",
       "104237                                  drug: nipocalimab   \n",
       "\n",
       "       Primary Outcome Measures Secondary Outcome Measures  \\\n",
       "11239                   unknown                       none   \n",
       "47190                   unknown                       none   \n",
       "53091                   unknown                       none   \n",
       "53366                   unknown                       none   \n",
       "104237                  unknown                       none   \n",
       "\n",
       "                                    Sponsor  \\\n",
       "11239          Cellphire Therapeutics, Inc.   \n",
       "47190                   Biotoxtech Co., Ltd   \n",
       "53091   Bennett, James P., Jr., M.D., Ph.D.   \n",
       "53366         Far Eastern Memorial Hospital   \n",
       "104237  Janssen Research & Development, LLC   \n",
       "\n",
       "                                          Collaborators      Sex  \\\n",
       "11239                                              none      ALL   \n",
       "47190                                              none     MALE   \n",
       "53091   University of Pittsburgh|University of Nebraska      ALL   \n",
       "53366                                              none      ALL   \n",
       "104237                                             none  unknown   \n",
       "\n",
       "                              Age    Phases  Enrollment Funder Type  \\\n",
       "11239          ADULT, OLDER_ADULT  NO PHASE          69    INDUSTRY   \n",
       "47190                       ADULT  NO PHASE          69    INDUSTRY   \n",
       "53091          ADULT, OLDER_ADULT  NO PHASE          69       INDIV   \n",
       "53366   CHILD, ADULT, OLDER_ADULT  NO PHASE          69       OTHER   \n",
       "104237  CHILD, ADULT, OLDER_ADULT  NO PHASE          69    INDUSTRY   \n",
       "\n",
       "             Study Type Study Design Start Date Primary Completion Date  \\\n",
       "11239   EXPANDED_ACCESS      unknown    unknown                 unknown   \n",
       "47190   EXPANDED_ACCESS      unknown    unknown                 unknown   \n",
       "53091   EXPANDED_ACCESS      unknown    unknown                 unknown   \n",
       "53366   EXPANDED_ACCESS      unknown    unknown                 unknown   \n",
       "104237  EXPANDED_ACCESS      unknown    unknown                 unknown   \n",
       "\n",
       "       Completion Date First Posted Last Update Posted  \\\n",
       "11239          unknown   2020-11-06         2022-01-28   \n",
       "47190          unknown   2013-06-28         2013-06-28   \n",
       "53091          unknown   2008-01-16         2012-07-25   \n",
       "53366          unknown   2010-12-20         2010-12-20   \n",
       "104237         unknown   2022-02-03         2024-01-23   \n",
       "\n",
       "                                                Locations  \n",
       "11239                                             unknown  \n",
       "47190   Asan Medical Center, Special City of Seoul, Ko...  \n",
       "53091                                             unknown  \n",
       "53366                                             unknown  \n",
       "104237                                            unknown  "
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# slice out rows where study status is TEMPORARILY_NOT_AVAILABLE\n",
    "df[df['Study Status'] == 'TEMPORARILY_NOT_AVAILABLE'].head()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6e82c4a6-e3f3-4f37-9d7b-b2a0acd78afb",
   "metadata": {},
   "source": [
    "We can see that the rows where **(Study Status = Temporarily_not_available)** are missing a lot of information in the columns `Outcome_measures`, `Collaborators`, `Study Design`, and some `Locations`. Since this study status is neither completed or terminated, it doesn't provide any meaningful information to the model and we should remove these rows from the dataset."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "d3c80ef3-5086-4615-b3d0-244804094b0b",
   "metadata": {},
   "outputs": [],
   "source": [
    "# drop rows where study status = temp_not_available\n",
    "df.drop(index = df[df['Study Status'] == 'TEMPORARILY_NOT_AVAILABLE'].index, inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "5926c856-5111-4d8d-8dde-95b13ed3b0d6",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "COMPLETED                  263380\n",
       "RECRUITING                  66150\n",
       "UNKNOWN                     64828\n",
       "TERMINATED                  28014\n",
       "NOT_YET_RECRUITING          20055\n",
       "ACTIVE_NOT_RECRUITING       19702\n",
       "WITHDRAWN                   13716\n",
       "ENROLLING_BY_INVITATION      3931\n",
       "SUSPENDED                    1646\n",
       "NO_LONGER_AVAILABLE           446\n",
       "AVAILABLE                     259\n",
       "APPROVED_FOR_MARKETING        197\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 33,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Sanity check\n",
    "df['Study Status'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2478d340-5bde-4cb1-8670-d13e3fffef37",
   "metadata": {},
   "source": [
    "Next we should look at `APPROVED_FOR_MARKETING` status, and see where we can group those."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "d506a6db-d46b-4fe7-8ebd-af344d6f65a8",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>8036</th>\n",
       "      <td>Expanded Access of Pimavanserin for Patients W...</td>\n",
       "      <td>APPROVED_FOR_MARKETING</td>\n",
       "      <td>The purpose of this program is to provide pati...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Parkinson's Disease Psychosis</td>\n",
       "      <td>drug: pimavanserin tartrate</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>ACADIA Pharmaceuticals Inc.</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2016-05-05</td>\n",
       "      <td>2017-04-18</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8345</th>\n",
       "      <td>18F-FDG PET Imaging in Cardiac Sarcoidosis</td>\n",
       "      <td>APPROVED_FOR_MARKETING</td>\n",
       "      <td>This study has been designed to provide patien...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cardiac Sarcoidosis</td>\n",
       "      <td>other: 18f-fluorodeoxyglucose (18f-fdg) pet/ct</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>British Columbia Cancer Agency</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2013-01-09</td>\n",
       "      <td>2022-02-04</td>\n",
       "      <td>BC Cancer Agency, Vancouver, British Columbia,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8886</th>\n",
       "      <td>Early Access Treatment With Daratumumab for (R...</td>\n",
       "      <td>APPROVED_FOR_MARKETING</td>\n",
       "      <td>The objective of this study is to provide earl...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Multiple Myeloma</td>\n",
       "      <td>drug: daratumumab</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Janssen Research &amp; Development, LLC</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2015-06-23</td>\n",
       "      <td>2019-01-15</td>\n",
       "      <td>Phoenix, Arizona, United States|Little Rock, A...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10306</th>\n",
       "      <td>An Expanded Access Treatment Protocol of Enfor...</td>\n",
       "      <td>APPROVED_FOR_MARKETING</td>\n",
       "      <td>The primary purpose of this expanded access pr...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Locally Advanced or Metastatic Urothelial Carc...</td>\n",
       "      <td>drug: enfortumab vedotin (ev)</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Astellas Pharma Global Development, Inc.</td>\n",
       "      <td>Seagen Inc.</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2019-10-23</td>\n",
       "      <td>2020-01-13</td>\n",
       "      <td>UCLA Hematology Oncology, Los Angeles, Califor...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11729</th>\n",
       "      <td>An Expanded Access Study to Provide at Home Su...</td>\n",
       "      <td>APPROVED_FOR_MARKETING</td>\n",
       "      <td>This single arm, multicenter study provides th...</td>\n",
       "      <td>NO</td>\n",
       "      <td>HER2-positive Breast Cancer</td>\n",
       "      <td>drug: pertuzumab and trastuzumab fixed-dose co...</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Genentech, Inc.</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2020-05-20</td>\n",
       "      <td>2022-07-05</td>\n",
       "      <td>Beverly Hills Cancer Center, Beverly Hills, Ca...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                             Study Title  \\\n",
       "8036   Expanded Access of Pimavanserin for Patients W...   \n",
       "8345          18F-FDG PET Imaging in Cardiac Sarcoidosis   \n",
       "8886   Early Access Treatment With Daratumumab for (R...   \n",
       "10306  An Expanded Access Treatment Protocol of Enfor...   \n",
       "11729  An Expanded Access Study to Provide at Home Su...   \n",
       "\n",
       "                 Study Status  \\\n",
       "8036   APPROVED_FOR_MARKETING   \n",
       "8345   APPROVED_FOR_MARKETING   \n",
       "8886   APPROVED_FOR_MARKETING   \n",
       "10306  APPROVED_FOR_MARKETING   \n",
       "11729  APPROVED_FOR_MARKETING   \n",
       "\n",
       "                                           Brief Summary Study Results  \\\n",
       "8036   The purpose of this program is to provide pati...            NO   \n",
       "8345   This study has been designed to provide patien...            NO   \n",
       "8886   The objective of this study is to provide earl...            NO   \n",
       "10306  The primary purpose of this expanded access pr...            NO   \n",
       "11729  This single arm, multicenter study provides th...            NO   \n",
       "\n",
       "                                              Conditions  \\\n",
       "8036                       Parkinson's Disease Psychosis   \n",
       "8345                                 Cardiac Sarcoidosis   \n",
       "8886                                    Multiple Myeloma   \n",
       "10306  Locally Advanced or Metastatic Urothelial Carc...   \n",
       "11729                        HER2-positive Breast Cancer   \n",
       "\n",
       "                                           Interventions  \\\n",
       "8036                         drug: pimavanserin tartrate   \n",
       "8345      other: 18f-fluorodeoxyglucose (18f-fdg) pet/ct   \n",
       "8886                                   drug: daratumumab   \n",
       "10306                      drug: enfortumab vedotin (ev)   \n",
       "11729  drug: pertuzumab and trastuzumab fixed-dose co...   \n",
       "\n",
       "      Primary Outcome Measures Secondary Outcome Measures  \\\n",
       "8036                   unknown                       none   \n",
       "8345                   unknown                       none   \n",
       "8886                   unknown                       none   \n",
       "10306                  unknown                       none   \n",
       "11729                  unknown                       none   \n",
       "\n",
       "                                        Sponsor Collaborators  Sex  \\\n",
       "8036                ACADIA Pharmaceuticals Inc.          none  ALL   \n",
       "8345             British Columbia Cancer Agency          none  ALL   \n",
       "8886        Janssen Research & Development, LLC          none  ALL   \n",
       "10306  Astellas Pharma Global Development, Inc.   Seagen Inc.  ALL   \n",
       "11729                           Genentech, Inc.          none  ALL   \n",
       "\n",
       "                      Age    Phases  Enrollment Funder Type       Study Type  \\\n",
       "8036   ADULT, OLDER_ADULT  NO PHASE          69    INDUSTRY  EXPANDED_ACCESS   \n",
       "8345   ADULT, OLDER_ADULT  NO PHASE          69       OTHER  EXPANDED_ACCESS   \n",
       "8886   ADULT, OLDER_ADULT  NO PHASE          69    INDUSTRY  EXPANDED_ACCESS   \n",
       "10306  ADULT, OLDER_ADULT  NO PHASE          69    INDUSTRY  EXPANDED_ACCESS   \n",
       "11729  ADULT, OLDER_ADULT  NO PHASE          69    INDUSTRY  EXPANDED_ACCESS   \n",
       "\n",
       "      Study Design Start Date Primary Completion Date Completion Date  \\\n",
       "8036       unknown    unknown                 unknown         unknown   \n",
       "8345       unknown    unknown                 unknown         unknown   \n",
       "8886       unknown    unknown                 unknown         unknown   \n",
       "10306      unknown    unknown                 unknown         unknown   \n",
       "11729      unknown    unknown                 unknown         unknown   \n",
       "\n",
       "      First Posted Last Update Posted  \\\n",
       "8036    2016-05-05         2017-04-18   \n",
       "8345    2013-01-09         2022-02-04   \n",
       "8886    2015-06-23         2019-01-15   \n",
       "10306   2019-10-23         2020-01-13   \n",
       "11729   2020-05-20         2022-07-05   \n",
       "\n",
       "                                               Locations  \n",
       "8036                                             unknown  \n",
       "8345   BC Cancer Agency, Vancouver, British Columbia,...  \n",
       "8886   Phoenix, Arizona, United States|Little Rock, A...  \n",
       "10306  UCLA Hematology Oncology, Los Angeles, Califor...  \n",
       "11729  Beverly Hills Cancer Center, Beverly Hills, Ca...  "
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[df['Study Status'] == 'APPROVED_FOR_MARKETING'].head()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3431ae3a-277e-44fa-912d-6b12615a4aee",
   "metadata": {},
   "source": [
    "Simiar to the temp_not_available, the category `APPROVED_FOR_MARKETING` is missing a lot of information in the same categories and do not provide much insight into completed or terminated trials. We can drop these rows as well."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "ad4331cb-f0b4-4c4d-aea9-cd8d8fbaaeba",
   "metadata": {},
   "outputs": [],
   "source": [
    "# drop rows where study status = APPROVED_FOR_MARKETING\n",
    "df.drop(index = df[df['Study Status'] == 'APPROVED_FOR_MARKETING'].index, inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "7e286b2d-a254-48eb-b522-ba06d07f2659",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "COMPLETED                  263380\n",
       "RECRUITING                  66150\n",
       "UNKNOWN                     64828\n",
       "TERMINATED                  28014\n",
       "NOT_YET_RECRUITING          20055\n",
       "ACTIVE_NOT_RECRUITING       19702\n",
       "WITHDRAWN                   13716\n",
       "ENROLLING_BY_INVITATION      3931\n",
       "SUSPENDED                    1646\n",
       "NO_LONGER_AVAILABLE           446\n",
       "AVAILABLE                     259\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 36,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Sanity check\n",
    "df['Study Status'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4abf9caa-82b8-4d55-a873-497b1e9fb074",
   "metadata": {},
   "source": [
    "Now, we will look into the `AVAILABLE` category to see where we can group those."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "6b969b46-b334-483b-bfac-23a40dd6f227",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1049</th>\n",
       "      <td>Expanded Access to Ensartinib for Participants...</td>\n",
       "      <td>AVAILABLE</td>\n",
       "      <td>This is an open-label, multicenter, intermedia...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Non-Small Cell Lung Cancer|ALK Gene Rearrangem...</td>\n",
       "      <td>drug: ensartinib</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Xcovery Holdings, Inc.</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2019-10-31</td>\n",
       "      <td>2022-10-20</td>\n",
       "      <td>Stanford University, Stanford, California, 943...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2621</th>\n",
       "      <td>Intermediate-size Expanded Access Program (EAP...</td>\n",
       "      <td>AVAILABLE</td>\n",
       "      <td>The objectives of this intermediate-size expan...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Multisystem Inflammatory Syndrome in Children ...</td>\n",
       "      <td>biological: remestemcel-l|drug: hydrocortisone...</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Mesoblast International SÃ rl</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2020-07-02</td>\n",
       "      <td>2023-05-06</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3931</th>\n",
       "      <td>Chronic Effect of Mat Pilates on Neuromotor, C...</td>\n",
       "      <td>AVAILABLE</td>\n",
       "      <td>The Pilates method aims to develop conscious c...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Stroke|High Blood Pressure</td>\n",
       "      <td>other: mat pilates</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Rio de Janeiro State University</td>\n",
       "      <td>Postgraduate scholarship</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2024-02-05</td>\n",
       "      <td>2024-02-14</td>\n",
       "      <td>Jeferson Silva da Rocha, Rio De Janeiro, 20550...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6425</th>\n",
       "      <td>Chelated Oral Iron Versus Intravenous Iron Suc...</td>\n",
       "      <td>AVAILABLE</td>\n",
       "      <td>compare the efficacy and safety of intravenous...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Iron Deficiency Anemia of Pregnancy</td>\n",
       "      <td>drug: chelated iron|drug: iron sucrose</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Assiut University</td>\n",
       "      <td>none</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2021-12-09</td>\n",
       "      <td>2021-12-09</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7385</th>\n",
       "      <td>A Cohort IND Expanded Access Program for Suppo...</td>\n",
       "      <td>AVAILABLE</td>\n",
       "      <td>This Expanded Access Program aims to:\\n\\n1. Pr...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Uveal Melanoma</td>\n",
       "      <td>drug: tebentafusp</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Immunocore Ltd</td>\n",
       "      <td>Clinigen, Inc.</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2021-07-14</td>\n",
       "      <td>2022-01-21</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                            Study Title Study Status  \\\n",
       "1049  Expanded Access to Ensartinib for Participants...    AVAILABLE   \n",
       "2621  Intermediate-size Expanded Access Program (EAP...    AVAILABLE   \n",
       "3931  Chronic Effect of Mat Pilates on Neuromotor, C...    AVAILABLE   \n",
       "6425  Chelated Oral Iron Versus Intravenous Iron Suc...    AVAILABLE   \n",
       "7385  A Cohort IND Expanded Access Program for Suppo...    AVAILABLE   \n",
       "\n",
       "                                          Brief Summary Study Results  \\\n",
       "1049  This is an open-label, multicenter, intermedia...            NO   \n",
       "2621  The objectives of this intermediate-size expan...            NO   \n",
       "3931  The Pilates method aims to develop conscious c...            NO   \n",
       "6425  compare the efficacy and safety of intravenous...            NO   \n",
       "7385  This Expanded Access Program aims to:\\n\\n1. Pr...            NO   \n",
       "\n",
       "                                             Conditions  \\\n",
       "1049  Non-Small Cell Lung Cancer|ALK Gene Rearrangem...   \n",
       "2621  Multisystem Inflammatory Syndrome in Children ...   \n",
       "3931                         Stroke|High Blood Pressure   \n",
       "6425                Iron Deficiency Anemia of Pregnancy   \n",
       "7385                                     Uveal Melanoma   \n",
       "\n",
       "                                          Interventions  \\\n",
       "1049                                   drug: ensartinib   \n",
       "2621  biological: remestemcel-l|drug: hydrocortisone...   \n",
       "3931                                 other: mat pilates   \n",
       "6425             drug: chelated iron|drug: iron sucrose   \n",
       "7385                                  drug: tebentafusp   \n",
       "\n",
       "     Primary Outcome Measures Secondary Outcome Measures  \\\n",
       "1049                  unknown                       none   \n",
       "2621                  unknown                       none   \n",
       "3931                  unknown                       none   \n",
       "6425                  unknown                       none   \n",
       "7385                  unknown                       none   \n",
       "\n",
       "                              Sponsor             Collaborators     Sex  \\\n",
       "1049           Xcovery Holdings, Inc.                      none     ALL   \n",
       "2621     Mesoblast International SÃ rl                      none     ALL   \n",
       "3931  Rio de Janeiro State University  Postgraduate scholarship     ALL   \n",
       "6425                Assiut University                      none  FEMALE   \n",
       "7385                   Immunocore Ltd            Clinigen, Inc.     ALL   \n",
       "\n",
       "                     Age    Phases  Enrollment Funder Type       Study Type  \\\n",
       "1049  ADULT, OLDER_ADULT  NO PHASE          69    INDUSTRY  EXPANDED_ACCESS   \n",
       "2621               CHILD  NO PHASE          69    INDUSTRY  EXPANDED_ACCESS   \n",
       "3931  ADULT, OLDER_ADULT  NO PHASE          69       OTHER  EXPANDED_ACCESS   \n",
       "6425  ADULT, OLDER_ADULT  NO PHASE          69       OTHER  EXPANDED_ACCESS   \n",
       "7385  ADULT, OLDER_ADULT  NO PHASE          69    INDUSTRY  EXPANDED_ACCESS   \n",
       "\n",
       "     Study Design Start Date Primary Completion Date Completion Date  \\\n",
       "1049      unknown    unknown                 unknown         unknown   \n",
       "2621      unknown    unknown                 unknown         unknown   \n",
       "3931      unknown    unknown                 unknown         unknown   \n",
       "6425      unknown    unknown                 unknown         unknown   \n",
       "7385      unknown    unknown                 unknown         unknown   \n",
       "\n",
       "     First Posted Last Update Posted  \\\n",
       "1049   2019-10-31         2022-10-20   \n",
       "2621   2020-07-02         2023-05-06   \n",
       "3931   2024-02-05         2024-02-14   \n",
       "6425   2021-12-09         2021-12-09   \n",
       "7385   2021-07-14         2022-01-21   \n",
       "\n",
       "                                              Locations  \n",
       "1049  Stanford University, Stanford, California, 943...  \n",
       "2621                                            unknown  \n",
       "3931  Jeferson Silva da Rocha, Rio De Janeiro, 20550...  \n",
       "6425                                            unknown  \n",
       "7385                                            unknown  "
      ]
     },
     "execution_count": 38,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[df['Study Status'] == 'AVAILABLE'].head()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8dc5b63f-d0b9-4717-bdce-e2e1435eaf4e",
   "metadata": {},
   "source": [
    "These are the studies that are now available. However, this category is missing `Study Design`, some `Collaborators`, and `Outcome_measures`. These studies could still be waiting for more information to be filled in, so for now we will remove these rows as they will not affect our prediction model."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "0c0f998a-a6c7-4908-8440-cf5f7fd61b17",
   "metadata": {},
   "outputs": [],
   "source": [
    "# drop rows where study status = AVAILABLE\n",
    "df.drop(index = df[df['Study Status'] == 'AVAILABLE'].index, inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "id": "5116b7ec-fa2a-4ef6-ab1d-8939990c04fe",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "COMPLETED                  263380\n",
       "RECRUITING                  66150\n",
       "UNKNOWN                     64828\n",
       "TERMINATED                  28014\n",
       "NOT_YET_RECRUITING          20055\n",
       "ACTIVE_NOT_RECRUITING       19702\n",
       "WITHDRAWN                   13716\n",
       "ENROLLING_BY_INVITATION      3931\n",
       "SUSPENDED                    1646\n",
       "NO_LONGER_AVAILABLE           446\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 41,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Sanity check\n",
    "df['Study Status'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1c021259-28c2-40ae-a65f-0c5134b1fd83",
   "metadata": {},
   "source": [
    "The `NO_LONGER_AVAILABLE` status has 446 studies, let's see where we can group these."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "id": "c8fbeb30-db67-4d3e-83b6-b6936e2a6809",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>377539</th>\n",
       "      <td>Individual Patient Expanded Access IND of Hope...</td>\n",
       "      <td>NO_LONGER_AVAILABLE</td>\n",
       "      <td>The drug for this submission is Hope Bioscienc...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Pancreatic Cancer</td>\n",
       "      <td>biological: hb-admscs</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Hope Biosciences</td>\n",
       "      <td>none</td>\n",
       "      <td>MALE</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2019-09-12</td>\n",
       "      <td>2021-07-06</td>\n",
       "      <td>Hope Biosciences, Sugar Land, Texas, 77478, Un...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37043</th>\n",
       "      <td>Treatment Use of Generex Oral-lynâ¢ in Patients...</td>\n",
       "      <td>NO_LONGER_AVAILABLE</td>\n",
       "      <td>The objective of this Treatment IND protocol i...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Type 1 Diabetes Mellitus|Type 2 Diabetes Mellitus</td>\n",
       "      <td>drug: buccal insulin spray</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Generex Biotechnology Corp.</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2009-07-29</td>\n",
       "      <td>2013-03-20</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>69581</th>\n",
       "      <td>Predictive Clinical Diagnosis of Rheumatoid Ar...</td>\n",
       "      <td>NO_LONGER_AVAILABLE</td>\n",
       "      <td>The hypothesis for this clinical research proj...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Rheumatoid Arthritis</td>\n",
       "      <td>diagnostic_test: thermal imaging</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>North Florida Foundation for Research and Educ...</td>\n",
       "      <td>Vivadox|Infrared Cameras Incorporate</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2021-11-18</td>\n",
       "      <td>2021-11-26</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>195657</th>\n",
       "      <td>An Early Access Program For Ustekinumab In Par...</td>\n",
       "      <td>NO_LONGER_AVAILABLE</td>\n",
       "      <td>The purpose of this program is to provide earl...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Crohn Disease</td>\n",
       "      <td>drug: ustekinumab</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Janssen Research &amp; Development, LLC</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2017-12-05</td>\n",
       "      <td>2020-11-16</td>\n",
       "      <td>Hospital Nossa Senhora Das Gracas, Curitiba, 8...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>399410</th>\n",
       "      <td>Clinical Management Decisions for Recurrent Pr...</td>\n",
       "      <td>NO_LONGER_AVAILABLE</td>\n",
       "      <td>When evaluating prostate cancer patients for r...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>drug: [11c]acetate</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Wendell Yap, MD</td>\n",
       "      <td>University of Kansas Medical Center</td>\n",
       "      <td>MALE</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2013-01-28</td>\n",
       "      <td>2018-05-16</td>\n",
       "      <td>University of Kansas Medical Center, Kansas Ci...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              Study Title  \\\n",
       "377539  Individual Patient Expanded Access IND of Hope...   \n",
       "37043   Treatment Use of Generex Oral-lynâ¢ in Patients...   \n",
       "69581   Predictive Clinical Diagnosis of Rheumatoid Ar...   \n",
       "195657  An Early Access Program For Ustekinumab In Par...   \n",
       "399410  Clinical Management Decisions for Recurrent Pr...   \n",
       "\n",
       "               Study Status  \\\n",
       "377539  NO_LONGER_AVAILABLE   \n",
       "37043   NO_LONGER_AVAILABLE   \n",
       "69581   NO_LONGER_AVAILABLE   \n",
       "195657  NO_LONGER_AVAILABLE   \n",
       "399410  NO_LONGER_AVAILABLE   \n",
       "\n",
       "                                            Brief Summary Study Results  \\\n",
       "377539  The drug for this submission is Hope Bioscienc...            NO   \n",
       "37043   The objective of this Treatment IND protocol i...            NO   \n",
       "69581   The hypothesis for this clinical research proj...            NO   \n",
       "195657  The purpose of this program is to provide earl...            NO   \n",
       "399410  When evaluating prostate cancer patients for r...            NO   \n",
       "\n",
       "                                               Conditions  \\\n",
       "377539                                  Pancreatic Cancer   \n",
       "37043   Type 1 Diabetes Mellitus|Type 2 Diabetes Mellitus   \n",
       "69581                                Rheumatoid Arthritis   \n",
       "195657                                      Crohn Disease   \n",
       "399410                                    Prostate Cancer   \n",
       "\n",
       "                           Interventions Primary Outcome Measures  \\\n",
       "377539             biological: hb-admscs                  unknown   \n",
       "37043         drug: buccal insulin spray                  unknown   \n",
       "69581   diagnostic_test: thermal imaging                  unknown   \n",
       "195657                 drug: ustekinumab                  unknown   \n",
       "399410                drug: [11c]acetate                  unknown   \n",
       "\n",
       "       Secondary Outcome Measures  \\\n",
       "377539                       none   \n",
       "37043                        none   \n",
       "69581                        none   \n",
       "195657                       none   \n",
       "399410                       none   \n",
       "\n",
       "                                                  Sponsor  \\\n",
       "377539                                   Hope Biosciences   \n",
       "37043                         Generex Biotechnology Corp.   \n",
       "69581   North Florida Foundation for Research and Educ...   \n",
       "195657                Janssen Research & Development, LLC   \n",
       "399410                                    Wendell Yap, MD   \n",
       "\n",
       "                               Collaborators   Sex                        Age  \\\n",
       "377539                                  none  MALE  CHILD, ADULT, OLDER_ADULT   \n",
       "37043                                   none   ALL  CHILD, ADULT, OLDER_ADULT   \n",
       "69581   Vivadox|Infrared Cameras Incorporate   ALL         ADULT, OLDER_ADULT   \n",
       "195657                                  none   ALL         ADULT, OLDER_ADULT   \n",
       "399410   University of Kansas Medical Center  MALE         ADULT, OLDER_ADULT   \n",
       "\n",
       "          Phases  Enrollment Funder Type       Study Type Study Design  \\\n",
       "377539  NO PHASE          69    INDUSTRY  EXPANDED_ACCESS      unknown   \n",
       "37043   NO PHASE          69    INDUSTRY  EXPANDED_ACCESS      unknown   \n",
       "69581   NO PHASE          69       OTHER  EXPANDED_ACCESS      unknown   \n",
       "195657  NO PHASE          69    INDUSTRY  EXPANDED_ACCESS      unknown   \n",
       "399410  NO PHASE          69       OTHER  EXPANDED_ACCESS      unknown   \n",
       "\n",
       "       Start Date Primary Completion Date Completion Date First Posted  \\\n",
       "377539    unknown                 unknown         unknown   2019-09-12   \n",
       "37043     unknown                 unknown         unknown   2009-07-29   \n",
       "69581     unknown                 unknown         unknown   2021-11-18   \n",
       "195657    unknown                 unknown         unknown   2017-12-05   \n",
       "399410    unknown                 unknown         unknown   2013-01-28   \n",
       "\n",
       "       Last Update Posted                                          Locations  \n",
       "377539         2021-07-06  Hope Biosciences, Sugar Land, Texas, 77478, Un...  \n",
       "37043          2013-03-20                                            unknown  \n",
       "69581          2021-11-26                                            unknown  \n",
       "195657         2020-11-16  Hospital Nossa Senhora Das Gracas, Curitiba, 8...  \n",
       "399410         2018-05-16  University of Kansas Medical Center, Kansas Ci...  "
      ]
     },
     "execution_count": 46,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[df['Study Status'] == 'NO_LONGER_AVAILABLE'].sample(5)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7326a1af-b3c9-47cd-bf40-1fbe0af1956d",
   "metadata": {},
   "source": [
    "Similarly with the AVAILABLE status, this category is missing information from `outcome_measures`, some `collaborators`, `Phases`, and `Study design`. We can remove these rows as well."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "id": "f948d9fd-d14f-4340-8f83-afcbf9fb408c",
   "metadata": {},
   "outputs": [],
   "source": [
    "# drop rows where study status = NO_LONGER_AVAILABLE\n",
    "df.drop(index = df[df['Study Status'] == 'NO_LONGER_AVAILABLE'].index, inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "id": "6fc7229b-413c-4421-8989-a3cec6d48477",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "COMPLETED                  263380\n",
       "RECRUITING                  66150\n",
       "UNKNOWN                     64828\n",
       "TERMINATED                  28014\n",
       "NOT_YET_RECRUITING          20055\n",
       "ACTIVE_NOT_RECRUITING       19702\n",
       "WITHDRAWN                   13716\n",
       "ENROLLING_BY_INVITATION      3931\n",
       "SUSPENDED                    1646\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 48,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Sanity check\n",
    "df['Study Status'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ad5142b1-9f0f-44c2-b18b-62c7eede0585",
   "metadata": {},
   "source": [
    "The suspended status is when studies are halted for an indefinite amount of time, but can resume when proper conditions are met. Let's see where we can group these statuses."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "id": "4efa25e1-6ad2-4811-b487-3c9aaeb097a3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>316858</th>\n",
       "      <td>Validation of the Critical-Care Pain Observati...</td>\n",
       "      <td>SUSPENDED</td>\n",
       "      <td>The aim of this study is to validate the Criti...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Pain|Intensive Care Units</td>\n",
       "      <td>diagnostic_test: critical care pain observatio...</td>\n",
       "      <td>Greek validation of the CPOT tool (Critical Ca...</td>\n",
       "      <td>Correlation of physiological parameters to CPO...</td>\n",
       "      <td>Saint Savvas Anticancer Hospital</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>74</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>2018-07-01</td>\n",
       "      <td>2020-10-01</td>\n",
       "      <td>2021-01-01</td>\n",
       "      <td>2018-08-31</td>\n",
       "      <td>2020-03-31</td>\n",
       "      <td>Saint Savvas Anticancer Hospital of Athens, At...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>429813</th>\n",
       "      <td>Biomarkers for Apatinib and Bevacizumab in Sec...</td>\n",
       "      <td>SUSPENDED</td>\n",
       "      <td>Bevacizumab, an antibody against vascular endo...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Colorectal Neoplasms</td>\n",
       "      <td>drug: apatinib mesylate tablets|drug: bevacizu...</td>\n",
       "      <td>Identify biomarkers specific to apatinib or be...</td>\n",
       "      <td>Progression-free Survival (PFS), PFS was defin...</td>\n",
       "      <td>Shenzhen People's Hospital</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>40</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2020-10-22</td>\n",
       "      <td>2025-12-31</td>\n",
       "      <td>2026-12-31</td>\n",
       "      <td>2018-11-16</td>\n",
       "      <td>2023-06-29</td>\n",
       "      <td>Shenzhen People's Hospital, Shenzhen, Guang Do...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>224119</th>\n",
       "      <td>Effect of Tonsillectomy on Longterm Renal Outc...</td>\n",
       "      <td>SUSPENDED</td>\n",
       "      <td>The effect of tonsillectomy therapy on IgA nep...</td>\n",
       "      <td>NO</td>\n",
       "      <td>IgA Nephropathy</td>\n",
       "      <td>procedure: tonsillectomy|other: non-tonsillectomy</td>\n",
       "      <td>Renal survival rate or Deterioration of renal ...</td>\n",
       "      <td>Remission of proteinuria (complete or partial)...</td>\n",
       "      <td>Sun Yat-sen University</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>100</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2011-03</td>\n",
       "      <td>2023-03</td>\n",
       "      <td>2023-03</td>\n",
       "      <td>2015-06-15</td>\n",
       "      <td>2021-09-23</td>\n",
       "      <td>The First Affiliated Hospital of Sun Yat-sen U...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>395066</th>\n",
       "      <td>Postoperative Hepatic Arterial Chemotherapy in...</td>\n",
       "      <td>SUSPENDED</td>\n",
       "      <td>Currently, no adjuvant study with hepatic arte...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Colorectal Cancer</td>\n",
       "      <td>drug: oxaliplatin hai|drug: oxaliplatin iv|dru...</td>\n",
       "      <td>18-month hepatic RFS rate, Assessed 18 months ...</td>\n",
       "      <td>none</td>\n",
       "      <td>Gustave Roussy, Cancer Campus, Grand Paris</td>\n",
       "      <td>National Cancer Institute, France</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2|PHASE3</td>\n",
       "      <td>104</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2015-05-26</td>\n",
       "      <td>2028-05</td>\n",
       "      <td>2028-05</td>\n",
       "      <td>2015-07-10</td>\n",
       "      <td>2023-08-22</td>\n",
       "      <td>Gustave Roussy Cancer Campus Grand Paris, Vill...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>221780</th>\n",
       "      <td>2 Dose Neuraxial Morphine for Prevention of PDPH</td>\n",
       "      <td>SUSPENDED</td>\n",
       "      <td>Neuraxial analgesia (most commonly continuous ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Postdural Puncture Headache</td>\n",
       "      <td>drug: morphine|drug: sterile normal saline</td>\n",
       "      <td>Percent of participants with postdural punctur...</td>\n",
       "      <td>Percent of participants in need for epidural b...</td>\n",
       "      <td>Columbia University</td>\n",
       "      <td>none</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>400</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2015-09</td>\n",
       "      <td>2025-06</td>\n",
       "      <td>2025-06</td>\n",
       "      <td>2015-06-16</td>\n",
       "      <td>2023-09-13</td>\n",
       "      <td>Rutgers University Medical School, Newark, New...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              Study Title Study Status  \\\n",
       "316858  Validation of the Critical-Care Pain Observati...    SUSPENDED   \n",
       "429813  Biomarkers for Apatinib and Bevacizumab in Sec...    SUSPENDED   \n",
       "224119  Effect of Tonsillectomy on Longterm Renal Outc...    SUSPENDED   \n",
       "395066  Postoperative Hepatic Arterial Chemotherapy in...    SUSPENDED   \n",
       "221780   2 Dose Neuraxial Morphine for Prevention of PDPH    SUSPENDED   \n",
       "\n",
       "                                            Brief Summary Study Results  \\\n",
       "316858  The aim of this study is to validate the Criti...            NO   \n",
       "429813  Bevacizumab, an antibody against vascular endo...            NO   \n",
       "224119  The effect of tonsillectomy therapy on IgA nep...            NO   \n",
       "395066  Currently, no adjuvant study with hepatic arte...            NO   \n",
       "221780  Neuraxial analgesia (most commonly continuous ...            NO   \n",
       "\n",
       "                         Conditions  \\\n",
       "316858    Pain|Intensive Care Units   \n",
       "429813         Colorectal Neoplasms   \n",
       "224119              IgA Nephropathy   \n",
       "395066            Colorectal Cancer   \n",
       "221780  Postdural Puncture Headache   \n",
       "\n",
       "                                            Interventions  \\\n",
       "316858  diagnostic_test: critical care pain observatio...   \n",
       "429813  drug: apatinib mesylate tablets|drug: bevacizu...   \n",
       "224119  procedure: tonsillectomy|other: non-tonsillectomy   \n",
       "395066  drug: oxaliplatin hai|drug: oxaliplatin iv|dru...   \n",
       "221780         drug: morphine|drug: sterile normal saline   \n",
       "\n",
       "                                 Primary Outcome Measures  \\\n",
       "316858  Greek validation of the CPOT tool (Critical Ca...   \n",
       "429813  Identify biomarkers specific to apatinib or be...   \n",
       "224119  Renal survival rate or Deterioration of renal ...   \n",
       "395066  18-month hepatic RFS rate, Assessed 18 months ...   \n",
       "221780  Percent of participants with postdural punctur...   \n",
       "\n",
       "                               Secondary Outcome Measures  \\\n",
       "316858  Correlation of physiological parameters to CPO...   \n",
       "429813  Progression-free Survival (PFS), PFS was defin...   \n",
       "224119  Remission of proteinuria (complete or partial)...   \n",
       "395066                                               none   \n",
       "221780  Percent of participants in need for epidural b...   \n",
       "\n",
       "                                           Sponsor  \\\n",
       "316858            Saint Savvas Anticancer Hospital   \n",
       "429813                  Shenzhen People's Hospital   \n",
       "224119                      Sun Yat-sen University   \n",
       "395066  Gustave Roussy, Cancer Campus, Grand Paris   \n",
       "221780                         Columbia University   \n",
       "\n",
       "                            Collaborators     Sex                 Age  \\\n",
       "316858                               none     ALL  ADULT, OLDER_ADULT   \n",
       "429813                               none     ALL  ADULT, OLDER_ADULT   \n",
       "224119                               none     ALL               ADULT   \n",
       "395066  National Cancer Institute, France     ALL  ADULT, OLDER_ADULT   \n",
       "221780                               none  FEMALE  ADULT, OLDER_ADULT   \n",
       "\n",
       "               Phases  Enrollment Funder Type      Study Type  \\\n",
       "316858       NO PHASE          74       OTHER  INTERVENTIONAL   \n",
       "429813       NO PHASE          40       OTHER  INTERVENTIONAL   \n",
       "224119       NO PHASE         100       OTHER  INTERVENTIONAL   \n",
       "395066  PHASE2|PHASE3         104       OTHER  INTERVENTIONAL   \n",
       "221780         PHASE4         400       OTHER  INTERVENTIONAL   \n",
       "\n",
       "                                             Study Design  Start Date  \\\n",
       "316858  Allocation: RANDOMIZED|Intervention Model: CRO...  2018-07-01   \n",
       "429813  Allocation: RANDOMIZED|Intervention Model: PAR...  2020-10-22   \n",
       "224119  Allocation: RANDOMIZED|Intervention Model: PAR...     2011-03   \n",
       "395066  Allocation: RANDOMIZED|Intervention Model: PAR...  2015-05-26   \n",
       "221780  Allocation: RANDOMIZED|Intervention Model: PAR...     2015-09   \n",
       "\n",
       "       Primary Completion Date Completion Date First Posted  \\\n",
       "316858              2020-10-01      2021-01-01   2018-08-31   \n",
       "429813              2025-12-31      2026-12-31   2018-11-16   \n",
       "224119                 2023-03         2023-03   2015-06-15   \n",
       "395066                 2028-05         2028-05   2015-07-10   \n",
       "221780                 2025-06         2025-06   2015-06-16   \n",
       "\n",
       "       Last Update Posted                                          Locations  \n",
       "316858         2020-03-31  Saint Savvas Anticancer Hospital of Athens, At...  \n",
       "429813         2023-06-29  Shenzhen People's Hospital, Shenzhen, Guang Do...  \n",
       "224119         2021-09-23  The First Affiliated Hospital of Sun Yat-sen U...  \n",
       "395066         2023-08-22  Gustave Roussy Cancer Campus Grand Paris, Vill...  \n",
       "221780         2023-09-13  Rutgers University Medical School, Newark, New...  "
      ]
     },
     "execution_count": 49,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[df['Study Status'] == 'SUSPENDED'].sample(5)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "72c09a70-e690-42b3-a14a-1f792e418264",
   "metadata": {},
   "source": [
    "If we look at the `Completion Date` column, we can see that some dates are set in the future (2025, 2028, etc). This means that these studies could potentially startup again when conditions are met. Therefore, we should remove these rows since they are neither completed or terminated."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "id": "0733e46b-0fa8-4a4b-be37-bf83e09c2cb3",
   "metadata": {},
   "outputs": [],
   "source": [
    "# drop rows where study status = SUSPENDED\n",
    "df.drop(index = df[df['Study Status'] == 'SUSPENDED'].index, inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "id": "eece0f00-039e-4fb0-a807-049ddf776203",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "COMPLETED                  263380\n",
       "RECRUITING                  66150\n",
       "UNKNOWN                     64828\n",
       "TERMINATED                  28014\n",
       "NOT_YET_RECRUITING          20055\n",
       "ACTIVE_NOT_RECRUITING       19702\n",
       "WITHDRAWN                   13716\n",
       "ENROLLING_BY_INVITATION      3931\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 58,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Sanity check\n",
    "df['Study Status'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b156f067-1e0c-40e3-af86-1f7087a42bb8",
   "metadata": {},
   "source": [
    "Now let's look at `ENROLLING_BY_INVITATION` to see where we can group these statuses with."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "id": "d851e8aa-25c0-4f82-884c-48c72bf223ab",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>383112</th>\n",
       "      <td>Musculoskeletal Disorders Among Egyptian Anest...</td>\n",
       "      <td>ENROLLING_BY_INVITATION</td>\n",
       "      <td>This cross-sectional online survey questionnai...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Musculoskeletal Disorders</td>\n",
       "      <td>other: no intervention</td>\n",
       "      <td>Prevalence of work related musculoskeletal dis...</td>\n",
       "      <td>Risk factors of work related musculoskeletal d...</td>\n",
       "      <td>Sohag University</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>150</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>2022-04-01</td>\n",
       "      <td>2022-09</td>\n",
       "      <td>2022-09</td>\n",
       "      <td>2022-04-12</td>\n",
       "      <td>2022-04-12</td>\n",
       "      <td>Sohag faculty of medicine, Aswan, Please Selec...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>324833</th>\n",
       "      <td>Combinatorial Single Cell Strategies for a Cro...</td>\n",
       "      <td>ENROLLING_BY_INVITATION</td>\n",
       "      <td>Inflammatory bowel disease (IBD), consisting o...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Crohn Disease</td>\n",
       "      <td>other: sample collection</td>\n",
       "      <td>The change in cellular composition (i.e., perc...</td>\n",
       "      <td>none</td>\n",
       "      <td>Vanderbilt University Medical Center</td>\n",
       "      <td>The Leona M. and Harry B. Helmsley Charitable ...</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>190</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>2019-12-17</td>\n",
       "      <td>2027-02</td>\n",
       "      <td>2027-02</td>\n",
       "      <td>2019-10-03</td>\n",
       "      <td>2023-10-27</td>\n",
       "      <td>Vanderbilt University Medical Center, Nashvill...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>242960</th>\n",
       "      <td>Posterior Cervical Fixation Study</td>\n",
       "      <td>ENROLLING_BY_INVITATION</td>\n",
       "      <td>The objective of this study is to evaluate the...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Degenerative Disc Disease|Craniocervical Injur...</td>\n",
       "      <td>unknown</td>\n",
       "      <td>Complications of Posterior Fixation System, Ra...</td>\n",
       "      <td>Percentage of subjects meeting minimal clinica...</td>\n",
       "      <td>NuVasive</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>150</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>2022-05-10</td>\n",
       "      <td>2024-03</td>\n",
       "      <td>2025-03</td>\n",
       "      <td>2021-02-25</td>\n",
       "      <td>2023-05-01</td>\n",
       "      <td>UC Irvine Medical Center, Orange, California, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>79278</th>\n",
       "      <td>The Effect of Hypercapnia on Physiological Par...</td>\n",
       "      <td>ENROLLING_BY_INVITATION</td>\n",
       "      <td>The aim of the project is to evaluate the effe...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Hypoxia|Hypercapnia|Cardiac Output, High</td>\n",
       "      <td>other: hypoxic|other: hypercapnic|other: hypox...</td>\n",
       "      <td>Changes in Cardiac output due to the induced h...</td>\n",
       "      <td>none</td>\n",
       "      <td>Czech Technical University in Prague</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>15</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>2022-06-26</td>\n",
       "      <td>2023-10-30</td>\n",
       "      <td>2024-06-30</td>\n",
       "      <td>2022-07-01</td>\n",
       "      <td>2022-07-01</td>\n",
       "      <td>Czech Technical University in Prague, Kladno, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>305562</th>\n",
       "      <td>Influence of Supervised Stabilization Exercise...</td>\n",
       "      <td>ENROLLING_BY_INVITATION</td>\n",
       "      <td>The aim of the study is to determine the impac...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Low Back Pain</td>\n",
       "      <td>other: experimental study</td>\n",
       "      <td>Modified Schober's Test, The test is used to a...</td>\n",
       "      <td>Body Mass Index (BMI), Each participant's weig...</td>\n",
       "      <td>Gdansk University of Physical Education and Sport</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>40</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>2021-04-01</td>\n",
       "      <td>2021-05-10</td>\n",
       "      <td>2024-10-31</td>\n",
       "      <td>2022-01-13</td>\n",
       "      <td>2022-09-13</td>\n",
       "      <td>Gdansk University of Physical Education and Sp...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              Study Title  \\\n",
       "383112  Musculoskeletal Disorders Among Egyptian Anest...   \n",
       "324833  Combinatorial Single Cell Strategies for a Cro...   \n",
       "242960                  Posterior Cervical Fixation Study   \n",
       "79278   The Effect of Hypercapnia on Physiological Par...   \n",
       "305562  Influence of Supervised Stabilization Exercise...   \n",
       "\n",
       "                   Study Status  \\\n",
       "383112  ENROLLING_BY_INVITATION   \n",
       "324833  ENROLLING_BY_INVITATION   \n",
       "242960  ENROLLING_BY_INVITATION   \n",
       "79278   ENROLLING_BY_INVITATION   \n",
       "305562  ENROLLING_BY_INVITATION   \n",
       "\n",
       "                                            Brief Summary Study Results  \\\n",
       "383112  This cross-sectional online survey questionnai...            NO   \n",
       "324833  Inflammatory bowel disease (IBD), consisting o...            NO   \n",
       "242960  The objective of this study is to evaluate the...            NO   \n",
       "79278   The aim of the project is to evaluate the effe...            NO   \n",
       "305562  The aim of the study is to determine the impac...            NO   \n",
       "\n",
       "                                               Conditions  \\\n",
       "383112                          Musculoskeletal Disorders   \n",
       "324833                                      Crohn Disease   \n",
       "242960  Degenerative Disc Disease|Craniocervical Injur...   \n",
       "79278            Hypoxia|Hypercapnia|Cardiac Output, High   \n",
       "305562                                      Low Back Pain   \n",
       "\n",
       "                                            Interventions  \\\n",
       "383112                             other: no intervention   \n",
       "324833                           other: sample collection   \n",
       "242960                                            unknown   \n",
       "79278   other: hypoxic|other: hypercapnic|other: hypox...   \n",
       "305562                          other: experimental study   \n",
       "\n",
       "                                 Primary Outcome Measures  \\\n",
       "383112  Prevalence of work related musculoskeletal dis...   \n",
       "324833  The change in cellular composition (i.e., perc...   \n",
       "242960  Complications of Posterior Fixation System, Ra...   \n",
       "79278   Changes in Cardiac output due to the induced h...   \n",
       "305562  Modified Schober's Test, The test is used to a...   \n",
       "\n",
       "                               Secondary Outcome Measures  \\\n",
       "383112  Risk factors of work related musculoskeletal d...   \n",
       "324833                                               none   \n",
       "242960  Percentage of subjects meeting minimal clinica...   \n",
       "79278                                                none   \n",
       "305562  Body Mass Index (BMI), Each participant's weig...   \n",
       "\n",
       "                                                  Sponsor  \\\n",
       "383112                                   Sohag University   \n",
       "324833               Vanderbilt University Medical Center   \n",
       "242960                                           NuVasive   \n",
       "79278                Czech Technical University in Prague   \n",
       "305562  Gdansk University of Physical Education and Sport   \n",
       "\n",
       "                                            Collaborators  Sex  \\\n",
       "383112                                               none  ALL   \n",
       "324833  The Leona M. and Harry B. Helmsley Charitable ...  ALL   \n",
       "242960                                               none  ALL   \n",
       "79278                                                none  ALL   \n",
       "305562                                               none  ALL   \n",
       "\n",
       "                       Age    Phases  Enrollment Funder Type      Study Type  \\\n",
       "383112  ADULT, OLDER_ADULT  NO PHASE         150       OTHER   OBSERVATIONAL   \n",
       "324833  ADULT, OLDER_ADULT  NO PHASE         190       OTHER   OBSERVATIONAL   \n",
       "242960  ADULT, OLDER_ADULT  NO PHASE         150    INDUSTRY   OBSERVATIONAL   \n",
       "79278                ADULT  NO PHASE          15       OTHER  INTERVENTIONAL   \n",
       "305562  ADULT, OLDER_ADULT  NO PHASE          40       OTHER  INTERVENTIONAL   \n",
       "\n",
       "                                             Study Design  Start Date  \\\n",
       "383112          Observational Model: |Time Perspective: p  2022-04-01   \n",
       "324833          Observational Model: |Time Perspective: p  2019-12-17   \n",
       "242960          Observational Model: |Time Perspective: p  2022-05-10   \n",
       "79278   Allocation: RANDOMIZED|Intervention Model: CRO...  2022-06-26   \n",
       "305562  Allocation: NON_RANDOMIZED|Intervention Model:...  2021-04-01   \n",
       "\n",
       "       Primary Completion Date Completion Date First Posted  \\\n",
       "383112                 2022-09         2022-09   2022-04-12   \n",
       "324833                 2027-02         2027-02   2019-10-03   \n",
       "242960                 2024-03         2025-03   2021-02-25   \n",
       "79278               2023-10-30      2024-06-30   2022-07-01   \n",
       "305562              2021-05-10      2024-10-31   2022-01-13   \n",
       "\n",
       "       Last Update Posted                                          Locations  \n",
       "383112         2022-04-12  Sohag faculty of medicine, Aswan, Please Selec...  \n",
       "324833         2023-10-27  Vanderbilt University Medical Center, Nashvill...  \n",
       "242960         2023-05-01  UC Irvine Medical Center, Orange, California, ...  \n",
       "79278          2022-07-01  Czech Technical University in Prague, Kladno, ...  \n",
       "305562         2022-09-13  Gdansk University of Physical Education and Sp...  "
      ]
     },
     "execution_count": 60,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[df['Study Status'] == 'ENROLLING_BY_INVITATION'].sample(5)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3471d96f-2966-4605-926f-950cbe87c777",
   "metadata": {},
   "source": [
    "The `ENROLLING_BY_INVITATION` status consists of studies that are currently selecting participants from a predetermine population for the research. Since this status is not within our scope of the problem, we can also remove these rows."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "id": "526897d0-3768-4b13-8720-cb43cb9d8e11",
   "metadata": {},
   "outputs": [],
   "source": [
    "# drop rows where study status = `ENROLLING_BY_INVITATION`\n",
    "df.drop(index = df[df['Study Status'] == 'ENROLLING_BY_INVITATION'].index, inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "id": "61bebed5-9fc8-46aa-be62-001594d5edb6",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "COMPLETED                263380\n",
       "RECRUITING                66150\n",
       "UNKNOWN                   64828\n",
       "TERMINATED                28014\n",
       "NOT_YET_RECRUITING        20055\n",
       "ACTIVE_NOT_RECRUITING     19702\n",
       "WITHDRAWN                 13716\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 62,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Sanity check\n",
    "df['Study Status'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cdd79bd2-bb74-440d-b94b-4049975af40f",
   "metadata": {},
   "source": [
    "Next we will look at the `WITHDRAWN` status which has 13,716 studies."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "id": "5447b29a-438c-436b-81e5-83fcb2b27ef1",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>219022</th>\n",
       "      <td>Study to Evaluate the Amount of Medications Th...</td>\n",
       "      <td>WITHDRAWN</td>\n",
       "      <td>Based on the limited amount of experience with...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Kidney Transplantation|Plasmapheresis</td>\n",
       "      <td>drug: tacrolimus|drug: mycophenolate mofetil|d...</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Sidney Kimmel Cancer Center at Thomas Jefferso...</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>0</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>2003-02</td>\n",
       "      <td>2009-09</td>\n",
       "      <td>2009-09</td>\n",
       "      <td>2005-09-20</td>\n",
       "      <td>2016-10-21</td>\n",
       "      <td>Columbia University, New York, New York, 10032...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>109986</th>\n",
       "      <td>A Study to Assess the Safety and Effectiveness...</td>\n",
       "      <td>WITHDRAWN</td>\n",
       "      <td>The purpose of this study is to assess the saf...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Human Immunodeficiency Virus-Type 1</td>\n",
       "      <td>drug: no intervention</td>\n",
       "      <td>Number of patients with incidence of adverse e...</td>\n",
       "      <td>Mean decrease of viral load at the end of trea...</td>\n",
       "      <td>Janssen Pharmaceutica</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>0</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>2014-01</td>\n",
       "      <td>2014-12</td>\n",
       "      <td>2014-12</td>\n",
       "      <td>2012-11-14</td>\n",
       "      <td>2015-12-02</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>180227</th>\n",
       "      <td>Safety of Omegaven in Pediatric Patients With ...</td>\n",
       "      <td>WITHDRAWN</td>\n",
       "      <td>This study will demonstrate Short-, mid-, and ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Parenteral Nutrition Associated Liver Disease|...</td>\n",
       "      <td>drug: omegavenÂ® (fish oil triglycerides) injec...</td>\n",
       "      <td>Incidence of:, 1. Incidence of EFAD\\n2. Incide...</td>\n",
       "      <td>none</td>\n",
       "      <td>Fresenius Kabi</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>0</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>2022-04-01</td>\n",
       "      <td>2028-05-01</td>\n",
       "      <td>2029-05-01</td>\n",
       "      <td>2021-03-19</td>\n",
       "      <td>2022-08-04</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>270059</th>\n",
       "      <td>DYNAMIC Study (DoxycYcliNe AMbulatoIre COVID-19)</td>\n",
       "      <td>WITHDRAWN</td>\n",
       "      <td>The aim of the study is to compare a treatment...</td>\n",
       "      <td>NO</td>\n",
       "      <td>COVID19</td>\n",
       "      <td>drug: doxycycline|drug: placebo</td>\n",
       "      <td>Percentage of Patients with Clinical Respirato...</td>\n",
       "      <td>Positive SARS-CoV-2 PCR Test, Number of positi...</td>\n",
       "      <td>Nantes University Hospital</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>0</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2021-02-01</td>\n",
       "      <td>2021-02-01</td>\n",
       "      <td>2021-02-01</td>\n",
       "      <td>2020-05-01</td>\n",
       "      <td>2022-04-20</td>\n",
       "      <td>CHU Avicenne - APHP, Bobigny, 93009, France|CH...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>356989</th>\n",
       "      <td>Individualized Locoregional Treatment of Initi...</td>\n",
       "      <td>WITHDRAWN</td>\n",
       "      <td>In clinically node-positive (cN+) breast cance...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>procedure: omission of axillary lymph node dis...</td>\n",
       "      <td>iDFS, Invasive disease-free survival, 5 years</td>\n",
       "      <td>none</td>\n",
       "      <td>Karolinska Institutet</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>0</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2021-01-01</td>\n",
       "      <td>2025-12-31</td>\n",
       "      <td>2029-12-31</td>\n",
       "      <td>2020-02-24</td>\n",
       "      <td>2021-02-25</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              Study Title Study Status  \\\n",
       "219022  Study to Evaluate the Amount of Medications Th...    WITHDRAWN   \n",
       "109986  A Study to Assess the Safety and Effectiveness...    WITHDRAWN   \n",
       "180227  Safety of Omegaven in Pediatric Patients With ...    WITHDRAWN   \n",
       "270059   DYNAMIC Study (DoxycYcliNe AMbulatoIre COVID-19)    WITHDRAWN   \n",
       "356989  Individualized Locoregional Treatment of Initi...    WITHDRAWN   \n",
       "\n",
       "                                            Brief Summary Study Results  \\\n",
       "219022  Based on the limited amount of experience with...            NO   \n",
       "109986  The purpose of this study is to assess the saf...            NO   \n",
       "180227  This study will demonstrate Short-, mid-, and ...            NO   \n",
       "270059  The aim of the study is to compare a treatment...            NO   \n",
       "356989  In clinically node-positive (cN+) breast cance...            NO   \n",
       "\n",
       "                                               Conditions  \\\n",
       "219022              Kidney Transplantation|Plasmapheresis   \n",
       "109986                Human Immunodeficiency Virus-Type 1   \n",
       "180227  Parenteral Nutrition Associated Liver Disease|...   \n",
       "270059                                            COVID19   \n",
       "356989                                      Breast Cancer   \n",
       "\n",
       "                                            Interventions  \\\n",
       "219022  drug: tacrolimus|drug: mycophenolate mofetil|d...   \n",
       "109986                              drug: no intervention   \n",
       "180227  drug: omegavenÂ® (fish oil triglycerides) injec...   \n",
       "270059                    drug: doxycycline|drug: placebo   \n",
       "356989  procedure: omission of axillary lymph node dis...   \n",
       "\n",
       "                                 Primary Outcome Measures  \\\n",
       "219022                                            unknown   \n",
       "109986  Number of patients with incidence of adverse e...   \n",
       "180227  Incidence of:, 1. Incidence of EFAD\\n2. Incide...   \n",
       "270059  Percentage of Patients with Clinical Respirato...   \n",
       "356989      iDFS, Invasive disease-free survival, 5 years   \n",
       "\n",
       "                               Secondary Outcome Measures  \\\n",
       "219022                                               none   \n",
       "109986  Mean decrease of viral load at the end of trea...   \n",
       "180227                                               none   \n",
       "270059  Positive SARS-CoV-2 PCR Test, Number of positi...   \n",
       "356989                                               none   \n",
       "\n",
       "                                                  Sponsor Collaborators  Sex  \\\n",
       "219022  Sidney Kimmel Cancer Center at Thomas Jefferso...          none  ALL   \n",
       "109986                              Janssen Pharmaceutica          none  ALL   \n",
       "180227                                     Fresenius Kabi          none  ALL   \n",
       "270059                         Nantes University Hospital          none  ALL   \n",
       "356989                              Karolinska Institutet          none  ALL   \n",
       "\n",
       "                              Age    Phases  Enrollment Funder Type  \\\n",
       "219022         ADULT, OLDER_ADULT  NO PHASE           0       OTHER   \n",
       "109986         ADULT, OLDER_ADULT  NO PHASE           0    INDUSTRY   \n",
       "180227  CHILD, ADULT, OLDER_ADULT  NO PHASE           0    INDUSTRY   \n",
       "270059         ADULT, OLDER_ADULT    PHASE3           0       OTHER   \n",
       "356989         ADULT, OLDER_ADULT    PHASE3           0       OTHER   \n",
       "\n",
       "            Study Type                                       Study Design  \\\n",
       "219022   OBSERVATIONAL          Observational Model: |Time Perspective: p   \n",
       "109986   OBSERVATIONAL          Observational Model: |Time Perspective: p   \n",
       "180227   OBSERVATIONAL          Observational Model: |Time Perspective: p   \n",
       "270059  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "356989  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "\n",
       "        Start Date Primary Completion Date Completion Date First Posted  \\\n",
       "219022     2003-02                 2009-09         2009-09   2005-09-20   \n",
       "109986     2014-01                 2014-12         2014-12   2012-11-14   \n",
       "180227  2022-04-01              2028-05-01      2029-05-01   2021-03-19   \n",
       "270059  2021-02-01              2021-02-01      2021-02-01   2020-05-01   \n",
       "356989  2021-01-01              2025-12-31      2029-12-31   2020-02-24   \n",
       "\n",
       "       Last Update Posted                                          Locations  \n",
       "219022         2016-10-21  Columbia University, New York, New York, 10032...  \n",
       "109986         2015-12-02                                            unknown  \n",
       "180227         2022-08-04                                            unknown  \n",
       "270059         2022-04-20  CHU Avicenne - APHP, Bobigny, 93009, France|CH...  \n",
       "356989         2021-02-25                                            unknown  "
      ]
     },
     "execution_count": 63,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[df['Study Status'] == 'WITHDRAWN'].sample(5)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "fb95a431-cfef-419c-a967-040c4b8064d1",
   "metadata": {},
   "source": [
    "Withdrawn are finished studies that have stopped prematurely before enrolling it's first participant. Since this status essentially has the same meaning as the terminated status, we will group this in the same category."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "id": "8ae62cb7-15d6-477b-886d-bf7f86f3040d",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Use np.where() to replace 'WITHDRAWN' with 'TERMINATED'\n",
    "df['Study Status'] = np.where(df['Study Status'] == 'WITHDRAWN', 'TERMINATED', df['Study Status'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "id": "75b2967a-c43a-4bf9-afb5-8bdb9e2a748f",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "COMPLETED                263380\n",
       "RECRUITING                66150\n",
       "UNKNOWN                   64828\n",
       "TERMINATED                41730\n",
       "NOT_YET_RECRUITING        20055\n",
       "ACTIVE_NOT_RECRUITING     19702\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 69,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Sanity check\n",
    "df['Study Status'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "7f5ad4d8-0afe-48b3-ba01-2df9bb8692a7",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "id": "30b2e239-f89b-47cb-87b4-c16ecbd8fce6",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "Index: 479776 entries, 0 to 482348\n",
      "Data columns (total 23 columns):\n",
      " #   Column                      Non-Null Count   Dtype \n",
      "---  ------                      --------------   ----- \n",
      " 0   Study Title                 479776 non-null  object\n",
      " 1   Study Status                479776 non-null  object\n",
      " 2   Brief Summary               479776 non-null  object\n",
      " 3   Study Results               479776 non-null  object\n",
      " 4   Conditions                  479776 non-null  object\n",
      " 5   Interventions               479776 non-null  object\n",
      " 6   Primary Outcome Measures    479776 non-null  object\n",
      " 7   Secondary Outcome Measures  479776 non-null  object\n",
      " 8   Sponsor                     479776 non-null  object\n",
      " 9   Collaborators               479776 non-null  object\n",
      " 10  Sex                         479776 non-null  object\n",
      " 11  Age                         479776 non-null  object\n",
      " 12  Phases                      479776 non-null  object\n",
      " 13  Enrollment                  479776 non-null  int64 \n",
      " 14  Funder Type                 479776 non-null  object\n",
      " 15  Study Type                  479776 non-null  object\n",
      " 16  Study Design                479776 non-null  object\n",
      " 17  Start Date                  479776 non-null  object\n",
      " 18  Primary Completion Date     479776 non-null  object\n",
      " 19  Completion Date             479776 non-null  object\n",
      " 20  First Posted                479776 non-null  object\n",
      " 21  Last Update Posted          479776 non-null  object\n",
      " 22  Locations                   479776 non-null  object\n",
      "dtypes: int64(1), object(22)\n",
      "memory usage: 87.8+ MB\n"
     ]
    }
   ],
   "source": [
    "df.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "id": "726b6404-ad8b-4c45-a7d9-84d5b077f766",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Results\n",
       "NO     419070\n",
       "YES     62352\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 56,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['Study Results'].value_counts()"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Clinical_Trials_env",
   "language": "python",
   "name": "clinical_trials_env"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
